Pharma stocks plunge as Trump’s 100% tariffs send shockwaves across Asia.
Hosted by Michelle Martin, we break down the impact on Singapore’s $4 billion pharma exports, Sumitomo Pharma, CSL, and more. Are these tariffs a short-term blow or a long-term reset for Asian healthcare investments?
Plus, we spotlight Mapletree’s three Singapore REITs - Logistics, Industrial, and Pan-Asia Commercial - amid expected rate cuts.
Which one offers the best dividend yield and growth potential?
Dividend Titan’s Willie Keng shares his strategy for navigating healthcare risks and REIT opportunities.

LIVE WELL WITH MICHELLE : Sustainability Impact Awards 2026 - Could Your Business Be Ready?
09:47

Market View: Quantum Computing Firms $2 Billion Grants from the US government, & Singapore is SEA biggest Stock Market
08:37

Money and Me: OCBC Is Winning, Tencent Is Falling & The ETF That Doubled
22:20